BioSpace News Archive

Press Releases

NMD Pharma Initiates Phase 2 Study of NMD670 in Patients with Charcot-Marie-Tooth Disease Type 1 and 2

November 18, 2024
·
5 min read
Press Releases

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

November 18, 2024
·
6 min read
Press Releases

BioCryst Launches ORLADEYO® (berotralstat) in Ireland

November 18, 2024
·
5 min read
Press Releases

Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy

November 18, 2024
·
7 min read
Press Releases

EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome

November 18, 2024
·
4 min read
Press Releases

Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors

November 18, 2024
·
2 min read
Press Releases

BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia

November 18, 2024
·
8 min read
Press Releases

Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer

November 18, 2024
·
4 min read
Press Releases

TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection

November 18, 2024
·
4 min read
Press Releases

Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

November 18, 2024
·
7 min read